Home › Funds › Bellevue Group AG › ORKA

Bellevue Group AG position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Bellevue Group AG reported holding 1,657,190 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$157.7M, representing 3.32% of its reported portfolio and ranking #6 among its reported holdings. Bellevue Group AG has disclosed ORKA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.66M sh
Reported value held$157.71M
Portfolio Weight3.32%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's ORKA position evolved

Bellevue Group AG first disclosed a stake in ORKA in Q1 2026 at 507,008 shares (US$24.9M). The position peaked in Q2 2026 at 1,657,190 shares, worth US$157.7M. Across 2 filings, Bellevue Group AG increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,657,190 shares valued at US$157.7M — an increase of 1,150,182 shares quarter over quarter.. Notable position changes include a 227% increase in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 507.01K $24.87M New
Q2 2026 1.66M $157.71M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 98 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Bellevue Group AG held ORKA?

Bellevue Group AG has disclosed ORKA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Bellevue Group AG's current position in ORKA?

As of Q2 2026, Bellevue Group AG holds 1.66M shares of ORKA (ORUKA THERAPEUTICS INC), valued at $157.71M, representing 3.32% of its reported portfolio and ranking #6.

Has Bellevue Group AG been buying or selling ORKA?

In the latest 13F filing (Q2 2026), Bellevue Group AG increased its position in ORKA. The position peaked in Q2 2026 at 1.66M shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 98 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.